UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?

Journal of Parkinson's disease, 2016-03, Vol.6 (1), p.39-51

Oueslati, Abid

2016

Volltextzugriff (PDF)

Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo

Proceedings of the National Academy of Sciences - PNAS, 2013-10, Vol.110 (41), p.E3945-E3954

2013

Volltextzugriff (PDF)

Alpha-Synuclein and the Endolysosomal System in Parkinson's Disease: Guilty by Association

Biomolecules (Basel, Switzerland), 2021-09, Vol.11 (9), p.1333

2021

Volltextzugriff (PDF)

Human-to-mouse prion-like propagation of mutant huntingtin protein

Acta neuropathologica, 2016-10, Vol.132 (4), p.577-592

2016

Volltextzugriff (PDF)

Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson’s disease

Proceedings of the National Academy of Sciences - PNAS, 2016-02, Vol.113 (7), p.E912-E921

2016

Volltextzugriff (PDF)

Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease

Neurobiology of disease, 2022-10, Vol.172, p.105833-105833, Article 105833

2022

Volltextzugriff (PDF)

Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson's Disease

PloS one, 2015-10, Vol.10 (10), p.e0140880

2015

Volltextzugriff (PDF)

Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology

Molecular psychiatry, 2021-09, Vol.26 (9), p.5441-5463

2021

Volltextzugriff (PDF)

Optimized protocol for the generation of functional human induced-pluripotent-stem-cell-derived dopaminergic neurons

STAR protocols, 2023-09, Vol.4 (3), p.102486-102486, Article 102486

2023

Volltextzugriff (PDF)

Optogenetic-mediated induction and monitoring of α-synuclein aggregation in cellular models of Parkinson’s disease

STAR protocols, 2023-12, Vol.4 (4), p.102738-102738, Article 102738

2023

Volltextzugriff (PDF)

Corrigendum to “Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease” [Neurobiology of Disease, 2024 Jan:190:106376]

Neurobiology of disease, 2024-04, Vol.193, p.106444-106444, Article 106444

2024

Volltextzugriff (PDF)

Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease

Neurobiology of disease, 2024-01, Vol.190, p.106376-106376, Article 106376

2024

Volltextzugriff (PDF)

Phosphorylation of Synucleins by Members of the Polo-like Kinase Family

The Journal of biological chemistry, 2010-01, Vol.285 (4), p.2807-2822

2010

Volltextzugriff (PDF)

Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates

Neurobiology of disease, 2020-07, Vol.141, p.104951-104951, Article 104951

2020

Volltextzugriff (PDF)

Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization

Cell death & disease, 2023-11, Vol.14 (11), p.729-729, Article 729

2023

Volltextzugriff (PDF)

Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons

Scientific reports, 2022-10, Vol.12 (1), p.17176-17176, Article 17176

2022

Volltextzugriff (PDF)

Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains

Molecular neurodegeneration, 2023-11, Vol.18 (1), p.1-91, Article 91

2023

Volltextzugriff (PDF)

Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primates

Neurobiology of disease, 2020-07, Vol.141, p.104941-104941, Article 104941

2020

Volltextzugriff (PDF)

Correction: Shedding a new light on Huntington’s disease: how blood can both propagate and ameliorate disease pathology

Molecular psychiatry, 2021-09, Vol.26 (9), p.5464-5464

2021

Volltextzugriff (PDF)

Inhibiting cellular uptake of mutant huntingtin using a monoclonal antibody: Implications for the treatment of Huntington's disease

Neurobiology of disease, 2020-07, Vol.141, p.104943-104943, Article 104943

2020

Volltextzugriff (PDF)

The many faces of α-synuclein: from structure and toxicity to therapeutic target

Nature reviews. Neuroscience, 2013-01, Vol.14 (1), p.38-48

2013

Volltextzugriff (PDF)

Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies

Progress in brain research, 2010, Vol.183, p.115-145

2010

Volltextzugriff (PDF)

Polo-like kinase 2 regulates selective autophagic ?-synuclein clearance and suppresses its toxicity in vivo

Proceedings of the National Academy of Sciences - PNAS, 2013-10, Vol.110 (41), p.E3945-E3945

2013

Volltextzugriff (PDF)

Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies

Neurobiology of disease, 2009-10, Vol.36 (1), p.116-125

2009

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?

Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo

Alpha-Synuclein and the Endolysosomal System in Parkinson's Disease: Guilty by Association

Human-to-mouse prion-like propagation of mutant huntingtin protein

Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson’s disease

Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease

Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson's Disease

Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology

Optimized protocol for the generation of functional human induced-pluripotent-stem-cell-derived dopaminergic neurons

Optogenetic-mediated induction and monitoring of α-synuclein aggregation in cellular models of Parkinson’s disease

Corrigendum to “Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease” [Neurobiology of Disease, 2024 Jan:190:106376]

Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease

Phosphorylation of Synucleins by Members of the Polo-like Kinase Family

Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates

Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization

Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons

Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains

Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primates

Correction: Shedding a new light on Huntington’s disease: how blood can both propagate and ameliorate disease pathology

A light-inducible protein clustering system for in vivo analysis of α-synuclein aggregation in Parkinson disease

Inhibiting cellular uptake of mutant huntingtin using a monoclonal antibody: Implications for the treatment of Huntington's disease

The many faces of α-synuclein: from structure and toxicity to therapeutic target

Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies

Polo-like kinase 2 regulates selective autophagic ?-synuclein clearance and suppresses its toxicity in vivo

Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies

Suchergebnisse filtern